TB-500 is the product designation for this research material, which was analytically identified as Thymosin Beta-4. Thymosin Beta-4 is a 43-amino-acid peptide investigated in experimental systems involving G-actin binding and sequestration, actin cytoskeletal dynamics, cellular migration, angiogenic processes, and tissue-response mechanisms.
Vial Content: 10mg
Form: Lyophilized powder
Intended Use: Laboratory research only
For research use only. Not for human or veterinary use.